Financial reports
10-K
2023 FY
Annual report
27 Mar 24
10-Q
2023 Q3
Quarterly report
14 Nov 23
10-Q
2023 Q2
Quarterly report
14 Aug 23
ARS
2022 FY
Annual report to shareholders
28 Jul 23
10-Q
2023 Q1
Quarterly report
15 May 23
10-K
2022 FY
Annual report
20 Mar 23
10-Q
2022 Q3
Quarterly report
10 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
23 Mar 22
Current reports
8-K/A
Departure of Directors or Certain Officers
12 Oct 23
8-K
Material Modifications to Rights of Security Holders
11 Sep 23
8-K
LadRx Completes Non-Dilutive Financing Transaction for up to $11 Million with XOMA Corporation
26 Jun 23
8-K
LadRx Announces Reverse Stock Split
11 May 23
8-K
Departure of Directors or Certain Officers
30 Dec 22
8-K
Amendments to Articles of Incorporation or Bylaws
23 Sep 22
8-K
Submission of Matters to a Vote of Security Holders
27 Jul 22
8-K
Departure of Directors or Certain Officers
2 Jun 22
8-K
CytRx Announces Distribution of Series D Preferred Stock to Holders of its Common Stock
19 May 22
8-K
CytRx Issues Open Letter to Stockholders Regarding Recent Corporate Progress
21 Mar 22
Registration and prospectus
S-1
IPO registration
14 Apr 23
D/A
$18.24M in equity / options / securities to be acquired, sold $8.24M, 1 investor
28 Jul 22
8-A12G
Registration of securities
19 May 22
424B3
Prospectus supplement
25 Mar 22
S-1/A
IPO registration (amended)
23 Mar 22
S-1
IPO registration
4 Aug 21
D
$18.24M in equity / options / securities to be acquired, sold $8.24M, 1 investor
29 Jul 21
424B5
Prospectus supplement for primary offering
15 Jul 21
S-3/A
Shelf registration (amended)
14 May 21
S-3
Shelf registration
22 Apr 21
Proxies
DEF 14A
Definitive proxy
28 Jul 23
PRE 14A
Preliminary proxy
17 Jul 23
DEFA14A
Additional proxy soliciting materials
16 Jun 22
DEFA14A
Additional proxy soliciting materials
16 Jun 22
DEF 14A
Definitive proxy
16 Jun 22
PRE 14A
Preliminary proxy
3 Jun 22
DEFA14A
Additional proxy soliciting materials
17 Feb 22
DEF 14A
Definitive proxy
31 Jan 22
DEFA14A
Additional proxy soliciting materials
26 Jan 22
PRE 14A
Preliminary proxy
21 Jan 22
Other
EFFECT
Notice of effectiveness
28 Mar 22
CORRESP
Correspondence with SEC
23 Mar 22
UPLOAD
Letter from SEC
10 Aug 21
EFFECT
Notice of effectiveness
13 Jul 21
CORRESP
Correspondence with SEC
12 Jul 21
UPLOAD
Letter from SEC
29 Apr 21
UPLOAD
Letter from SEC
12 Aug 20
UPLOAD
Letter from SEC
31 Jul 20
UPLOAD
Letter from SEC
22 Jul 20
UPLOAD
Letter from SEC
13 Jul 20
Ownership
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 24
4
Joel K Caldwell
29 Jan 24
4
Cary J Claiborne
29 Jan 24
4
Jennifer K. Simpson
29 Jan 24
4
JOHN Y CALOZ
29 Jan 24
4
Stephen Snowdy
29 Jan 24
SC 13G/A
ARMISTICE CAPITAL, LLC
14 Feb 23
3
Cary J Claiborne
28 Jul 22
SC 13G
ARMISTICE CAPITAL, LLC
15 Feb 22
4
Stephen Snowdy
12 Jan 22